Paperpal Prime Logo

Advances in Therapy : Impact Factor & More

eISSN: 1865-8652pISSN: 0741-238X

Aims and Scope of Advances in Therapy

Advances in Therapy is a monthly peer-reviewed medical journal covering clinical medicine, especially research on pharmaceuticals. The Managing Editor is Clare Shepherd. The journal publishes original clinical research papers and review articles. The journal was established in 1984 and published by Health Communications. Since 2008 it has been published by Springer Science+Business Media. Less

Key Metrics

CiteScore
5
Eigenfactor
0.005 - 0.01
H-Index
74
Impact Factor
< 5
Scite Index
0.88 5-Year SI
SJR
Q1Pharmacology (medical)
SNIP
1.37
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Advances in Therapy

Advances in Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher SPRINGER
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1984
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Advances in Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Advances in Therapy

Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.
  • 6 Aug 2026
  • Advances in therapy
Treatment Strategies in Incident and Recurrent Hyperkalemia: Insights from the TRACK Study.
  • 5 Aug 2026
  • Advances in therapy
Impact of Loco-regional Anaesthetic Techniques Versus General Anaesthesia in Women Aged ≥ 65 Undergoing Primary Breast Cancer Surgery: A Systematic Review of the Literature.
  • 5 Aug 2026
  • Advances in therapy
Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review.
  • 5 Aug 2026
  • Advances in therapy
Real-World Effect of Ruxolitinib Cream: Decreased Use of Additional Topical Therapies and Limited Escalation to Systemic Treatments.
  • 5 Aug 2026
  • Advances in therapy
Clinical Outcomes with High-Dose Amoxycillin-Clavulanate Suspension in Children with Respiratory Tract Infections: A Prospective, Multicentre, Phase IV Study in India.
  • 5 Aug 2026
  • Advances in therapy
Longitudinal Dosing Patterns and Treatment Costs Among Patients with Spinal Muscular Atrophy Initiating Nusinersen and Risdiplam.
  • 6 Aug 2026
  • Advances in therapy
Treatment Strategies in Incident and Recurrent Hyperkalemia: Insights from the TRACK Study.
  • 5 Aug 2026
  • Advances in therapy
Impact of Loco-regional Anaesthetic Techniques Versus General Anaesthesia in Women Aged ≥ 65 Undergoing Primary Breast Cancer Surgery: A Systematic Review of the Literature.
  • 5 Aug 2026
  • Advances in therapy
Clinical Relevance of Bile Acid and Bile Acid-Related Therapy in Liver Cirrhosis: A Review.
  • 5 Aug 2026
  • Advances in therapy
Real-World Effect of Ruxolitinib Cream: Decreased Use of Additional Topical Therapies and Limited Escalation to Systemic Treatments.
  • 5 Aug 2026
  • Advances in therapy
Clinical Outcomes with High-Dose Amoxycillin-Clavulanate Suspension in Children with Respiratory Tract Infections: A Prospective, Multicentre, Phase IV Study in India.
  • 5 Aug 2026
  • Advances in therapy

FAQs on Advances in Therapy